Genotype-phenotype correlations in pseudohypoparathyroidism type 1a patients: a systemic review
European Journal of Endocrinology · 08.11.2023 · 189 (5) · S103-S111
DOI: 10.1093/ejendo/lvad142 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift European Journal of Endocrinology, online erschienen am 14.10.2023. Verfasst von Siqi Jiang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology, Key Laboratory of Endocrinology, National Health Commission, Peking Union Medical College Hospital, Chinese Academy of M…. Hauptthemen laut MEDLINE: Chromogranins, Pseudohypoparathyroidism. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 38 Literaturangaben. Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Background
Pseudohypoparathyroidism type 1a (PHP1a) is a rare endocrine disease caused by partial defects of the α subunit of the stimulatory Guanosin triphosphate (GTP) binding protein (Gsα) resulting from maternal GNAS gene variation. The clinical manifestations are related to PTH resistance (hypocalcemia, hyperphosphatemia, and elevated serum intact PTH) in the presence or absence of multihormone resistance, and Albright's hereditary osteodystrophy (AHO).
Objectives
To summarize the molecular genetics results and clinical characteristics as well as to explore the correlations between them.
Methods
Articles pertaining to PHP1a until May, 31, 2021 were reviewed and 527 patients with genetic diagnosis were included in the data analysis. The clinical characteristics and molecular genetics results of these patients were analyzed and compared to explore the correlations between them.
Results
A total of 258 GNAS rare variants (RVs) were identified in 527 patients. The RVs were most commonly found in exons 1 and 7 (17.6% each), with frameshift (36.8%), and missense (31.3%) being the main types of RVs. The median age of onset was 5.0 years old. The most common clinical manifestations were elevation of PTH (86.7%) and AHO (87.5%). Thyroid stimulating hormone resistance was the most common hormone resistance (75.5%) other than PTH resistance. Patients with missense and in-frame RVs had lower incidence rates of the round face (P = .001) and subcutaneous ossifications (P < .001) than those with loss-of-function (non-sense, frameshift, splicing site variants, and large deletions) variants.
Conclusions
This study revealed the correlation between loss-of-function RVs with round faces and subcutaneous ossifications in PHP 1a patients. Further exploration of genotype-phenotype correlations through more standardized and prospective studies with long-term follow-up is necessary.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Endocrinology, Key Laboratory of Endocrinology, National Health Commission, Peking Union Medical College Hospital, Chinese Academy of Medical Science & Peking Union Medical College, Beijing 100730, China.
ORCID-Profile: Siqi Jiang, Yi Yang, An Song, Yan Jiang, Mei Li, Min Nie, Ou Wang, Xiaoping Xing
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Jiang, S., Yang, Y., Song, A., Jiang, Y., Jiang, Y., Li, M., Xia, W., Nie, M., Wang, O., & Xing, X. (2023). Genotype-phenotype correlations in pseudohypoparathyroidism type 1a patients: a systemic review. European Journal of Endocrinology, 189(5), S103-S111. https://doi.org/10.1093/ejendo/lvad142
Vancouver
Jiang S, Yang Y, Song A, Jiang Y, Jiang Y, Li M, et al. Genotype-phenotype correlations in pseudohypoparathyroidism type 1a patients: a systemic review. European Journal of Endocrinology. 2023;189(5):S103-S111. doi:10.1093/ejendo/lvad142
BibTeX
@article{Jiang2023,
author = {Jiang, Siqi and Yang, Yi and Song, An and Jiang, Yue and Jiang, Yan and Li, Mei and Xia, Weibo and Nie, Min and Wang, Ou and Xing, Xiaoping},
title = {Genotype-phenotype correlations in pseudohypoparathyroidism type 1a patients: a systemic review},
journal = {European Journal of Endocrinology},
year = {2023},
volume = {189},
number = {5},
pages = {S103--S111},
doi = {10.1093/ejendo/lvad142}
}
EUVIMED